Export 4 results:
Author [ Title(Desc)] Type Year
Filters: Author is Wolff, Mark C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
I
L. A. Jackson, Chen, W. H., Stapleton, J. T., Dekker, C. L., Wald, A., Brady, R. C., Edupuganti, S., Winokur, P., Mulligan, M. J., Keyserling, H. L., Kotloff, K. L., Rouphael, N., Noah, D. L., Hill, H., and Wolff, M. C., “Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons.”, J Infect Dis, vol. 206, no. 6, pp. 811-20, 2012.
Q
D. L. Noah, Hill, H., Hines, D., E White, L., and Wolff, M. C., “Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure.”, Clin Vaccine Immunol, vol. 16, no. 4, pp. 558-66, 2009.
S
N. B. Halasa, Gerber, M. A., Berry, A. A., Anderson, E. L., Winokur, P., Keyserling, H., Eckard, A. Ross, Hill, H., Wolff, M. C., McNeal, M. M., Edwards, K. M., and Bernstein, D. I., “Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age.”, J Pediatric Infect Dis Soc, vol. 4, no. 3, pp. 214-24, 2015.
S. E. Frey, Houghton, M., Coates, S., Abrignani, S., Chien, D., Rosa, D., Pileri, P., Ray, R., Di Bisceglie, A. M., Rinella, P., Hill, H., Wolff, M. C., Schultze, V., Han, J. H., Scharschmidt, B., and Belshe, R. B., “Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults.”, Vaccine, vol. 28, no. 38, pp. 6367-73, 2010.